EKF Diagnostics Holdings plc

("EKF", the "Company", or the "Group")

 Investor Presentation - Revised start time

EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed global diagnostics business, announces a revised start time for its investor presentation taking place on Wednesday 20 March 2024.

Julian Baines, Executive Chair, and Stephen Young, Chief Financial Officer, will be hosting a live online presentation relating to the Company's full year results via the Investor Meet Company platform at the revised time of 3pm GMT on Wednesday 20 March 2024. The presentation is open to all existing and potential shareholders.

Investors can sign up to Investor Meet Company for free and register for the presentation here: https://www.investormeetcompany.com/ekf-diagnostics-holdings-plc/register-investor

Investors who already follow EKF on the Investor Meet Company platform will automatically be invited to the event at the new start time.

If the new time is no longer convenient, please note that a recording of the presentation, a PDF of the slides used, and responses to the Q&A session will be available on the Investor Meet Company platform afterwards.

About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com)

EKF is an AIM-listed global diagnostics business focussed on:

·   Point-of-Care analysers in the key areas of Hematology and Diabetes, as well as Central Laboratory products including clinical chemistry reagents, analysers and centrifuges

·   Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications, as well as other higher value Contract Manufacturing services

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.